Clinical Trial Update: Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an investigational drug plus chemotherapy in chemotherapy-naive small cell lung cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED